Dow Up 2.00% Nasdaq Up 1.66%

Impax Laboratories Inc. (IPXL)

-NasdaqGS
30.89 Up 0.16(0.52%) Feb 12, 4:00PM EST
|After Hours : 30.90 Up 0.01 (0.02%) Feb 12, 5:07PM EST
Prev Close:30.73
Open:30.98
Bid:N/A
Ask:45.20 x 500
1y Target Est:47.15
Beta:1.15058
Next Earnings Date:22-Feb-16IPXL Earnings announcement
Day's Range:30.17 - 31.13
52wk Range:30.17 - 52.10
Volume:580,590
Avg Vol (3m):668,890
Market Cap:2.18B
P/E (ttm):80.44
EPS (ttm):0.38
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for IPXL

Comparison

Symbol% ChgMkt Cap
IPXLUp 0.52%2.18B
MYLUp 0.98%20.57B

Key Statistics

Forward P/E (1 yr):13.67
P/S (ttm):3.04
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-15) :1.27
Quarterly EPS Est (Dec-15) :0.44
Mean Recommendation*:2.7
PEG Ratio (5 yr expected):0.71

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Impax Laboratories, Inc., a specialty pharmaceutical company, develops, manufactures, and markets bioequivalent pharmaceutical products. It operates in two segments, Global Pharmaceuticals Division and Impax Pharmaceuticals Division. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback